Sektor DiaMedica Therapeutics Inc.

Aktien

A2N9HB

CA25253X2077

DMAC

Biotechnologie

Markt geschlossen - 21:00:00 28.10.2026 Perf. 5 T Veränd. 1. Jan.
9.820 USD +13.00% Intraday Chart für DiaMedica Therapeutics Inc. +13.00% +23.37%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. Perf. 1 Jahr Perf. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Marktkap.($)
+13.00%+13.00%+18.03%+47.89%+23.37%+44.62%+356.74%+145.50%+148.99% 530 Mio.
+0.65%-3.36%-11.99%+15.75%+57.11%+36.98%+60.50%+6.07% - 64.14 Mrd.
+1.03%+2.66%-5.21%+3.69%+12.19%+12.22%+83.86%+210.62%+5’644.29% 55.53 Mrd.
+0.75%+1.21%+8.87%+10.61%+18.22%+12.41%+104.11%-15.29%+240.36% 53.03 Mrd.
+2.76%+0.87%+2.98%+14.86%+23.79%+27.92%+55.07%+8.50%+288.80% 45.99 Mrd.
+2.00%-3.39%+1.73%+12.98%+22.89%+17.83%+119.04%+2.41%+1’015.51% 42.45 Mrd.
+1.34%-2.86%-6.45%+2.64%+136.94%+224.43%+914.08%+534.35% - 40.45 Mrd.
+0.64%-3.95%+6.45%+6.99%+10.10%+11.15%+45.57%+7.13%+158.47% 32.25 Mrd.
-1.84%+44.95%+66.03%+106.05%+89.79%+106.94%+93.22%+33.39%+244.10% 34.47 Mrd.
-2.72%-0.44%-15.78%+14.42%+43.32%+23.18%-10.77%-61.94% - 24.23 Mrd.
+1.07%-3.61%-11.19%-4.82%-7.57%-16.22%-3.52%-69.02% - 22.1 Mrd.
+2.13%+3.13%-17.58%-6.87%-44.28%-41.33%+306.11%+227.75%+616.25% 21.18 Mrd.
+2.80%+4.56%+12.46%+21.32%+23.33%+19.32%+176.76%+215.27%+2’297.65% 19.38 Mrd.
+4.22%+8.44%+26.95%+55.55%+87.48%+99.00%+116.69%-14.77%+392.08% 17.85 Mrd.
+0.02%+3.60%+13.20%+25.67%+38.24%+42.34%+84.59%-15.38%+108.41% 16.69 Mrd.
+1.42%+2.63%+13.55%+17.29%+51.22%+65.39%+228.12%+204.60%+509.19% 16.42 Mrd.
+1.50%+4.46%+8.48%-1.92% - - - - - 16.39 Mrd.
+0.84%+2.13%+3.90%+7.62%+183.22%+166.23%+345.61%+1’427.61%+795.27% 15.33 Mrd.
+17.04%+15.61%+21.98%+18.82%+17.53%+20.50%-8.99%-25.23%+166.63% 16.04 Mrd.
+0.97%-2.23%-7.44%-12.02%+11.63%+3.84%+435.21% - - 13.21 Mrd.
Durchschnitt +2.49%+4.35%+6.45%+17.83%+42.03%+46.15%+184.32%+156.75%+901.86% 28.38 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt +1.50%+3.57%+4.35%+16.68%+41.77%+45.49%+165.44%+121.03%+1’254.72%
  1. Börse
  2. Aktien
  3. A2N9HB Aktie
  4. Sektor DiaMedica Therapeutics Inc.